Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 18.
A
Aboheimed, Ghada I;
AlRasheed, Maha M;
Almudimeegh, Sultan;
Peña-Guerra, Karla A;
Cardona-Londoño, Kelly J;
Salih, Mustafa A;
Seidahmed, Mohammed Z;
... Ruiz, Arnaud J; + view all
(2022)
Clinical, genetic, and functional characterization of the glycine receptor β-subunit A455P variant in a family affected by hyperekplexia syndrome.
Journal of Biological Chemistry
, Article 102018. 10.1016/j.jbc.2022.102018.
|
|
Aldabbagh, Yousif;
Islam, Anam;
Zhang, Weicong;
Whiting, Paul;
Ali, Afia B;
(2022)
Alzheimer’s Disease Enhanced Tonic Inhibition is Correlated With Upregulated Astrocyte GABA Transporter-3/4 in a Knock-In APP Mouse Model.
Frontiers in Pharmacology
, 13
, Article 822499. 10.3389/fphar.2022.822499.
|
B
|
Borella, Elisa;
Oosterholt, Sean;
Magni, Paolo;
Pasqua, Oscar Della;
(2022)
Characterisation of individual ferritin response in patients receiving chelation therapy.
British Journal of Clinical Pharmacology
10.1111/bcp.15290.
(In press).
|
C
|
Cogo, Susanna;
Ho, Franz Y;
Tosoni, Elena;
Tomkins, James E;
Tessari, Isabella;
Iannotta, Lucia;
Montine, Thomas J;
... Greggio, Elisa; + view all
(2022)
The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation.
Brain Research
, 1778
, Article 147781. 10.1016/j.brainres.2022.147781.
|
D
|
Di Donfrancesco, Alessia;
Massaro, Giulia;
Di Meo, Ivano;
Tiranti, Valeria;
Bottani, Emanuela;
Brunetti, Dario;
(2022)
Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective.
Pharmaceutics
, 14
(6)
, Article 1287. 10.3390/pharmaceutics14061287.
|
E
|
Eleftheriadou, D;
Berg, M;
Phillips, JB;
Shipley, RJ;
(2022)
A combined experimental and computational framework to evaluate the behavior of therapeutic cells for peripheral nerve regeneration.
Biotechnology and Bioengineering
10.1002/bit.28105.
(In press).
|
G
|
Gross, AS;
Harry, AC;
Clifton, CS;
Della Pasqua, O;
(2022)
Clinical Trial Diversity: An Opportunity for Improved Insight into the Determinants of Variability in Drug Response.
British Journal of Clinical Pharmacology
, 88
(6)
pp. 2700-2717.
10.1111/bcp.15242.
|
I
|
Islam, Anam;
Saito, Takashi;
Saido, Takaomi;
Ali, Afia B;
(2022)
Presubiculum principal cells are preserved from degeneration in knock-in APP/TAU mouse models of Alzheimer’s disease.
Seminars in Cell & Developmental Biology
10.1016/j.semcdb.2022.03.001.
(In press).
|
J
|
Johnson, RC;
Saez-Lopez, E;
Anagonou, ES;
Kpoton, GG;
Ayelo, AG;
Gnimavo, RS;
Mignanwande, FZ;
... Ramon-Garcia, S; + view all
(2022)
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
Trials
(In press).
|
K
|
Koçoğlu, Cemile;
Ferrari, Raffaele;
Roes, Maxime;
Vandeweyer, Geert;
Kooy, R Frank;
van Broeckhoven, Christine;
Manzoni, Claudia;
(2022)
Protein interaction network analysis reveals genetic enrichment of immune system genes in frontotemporal dementia.
Neurobiology of Aging
10.1016/j.neurobiolaging.2022.03.018.
(In press).
|
 |
L
|
Laranjeira, S;
Pellegrino, G;
Bhangra, KS;
Phillips, JB;
Shipley, RJ;
(2022)
In silico framework to inform the design of repair constructs for peripheral nerve injury repair.
Journal of the Royal Society Interface
, 19
(188)
, Article 20210824. 10.1098/rsif.2021.0824.
|
|
Liu, Y;
Uras, G;
Onuwaje, I;
Li, W;
Yao, H;
Xu, S;
Li, X;
... Xu, J; + view all
(2022)
Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease.
European Journal of Medicinal Chemistry
, 235
, Article 114305. 10.1016/j.ejmech.2022.114305.
|
M
|
Mamais, Adamantios;
Kaganovich, Alice;
Harvey, Kirsten;
(2022)
Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson's disease.
Neurobiology of Disease
, 169
, Article 105721. 10.1016/j.nbd.2022.105721.
|
 |
|
Mamais, Adamantios;
Kluss, Jillian H;
Bonet-Ponce, Luis;
Landeck, Natalie;
Langston, Rebekah G;
Smith, Nathan;
Beilina, Alexandra;
... Cookson, Mark R; + view all
(2022)
Correction: Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
PLOS Biology
, 20
(5)
, Article e3001621. 10.1371/journal.pbio.3001621.
|
|
Muliaditan, M;
Teutonico, D;
Ortega-Mur, F;
Ferre, S;
Della Pasqua, Oscar;
(2022)
Prediction of lung exposure to anti-tubercular drugs using plasma pharmacokinetic data: implications for dose selection.
European Journal of Pharmaceutical Sciences
, 173
, Article 106163. 10.1016/j.ejps.2022.106163.
|
N
|
Nardotto, GHB;
Bollela, VB;
Rocha, A;
Della Pasqua, O;
Lanchot, VL;
(2022)
No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients.
Clinical and Translational Science
, 15
(2)
pp. 514-523.
10.1111/cts.13169.
|
P
|
Poupon-Bejuit, L;
Hughes, MP;
Liu, W;
Geard, A;
Faour-Slika, N;
Whaler, S;
Massaro, G;
(2022)
A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease.
Scientific Reports
, 12
(1)
, Article 13825. 10.1038/s41598-022-17338-1.
|
|
T
|
Tallarico, M;
Leo, A;
Guarnieri, L;
Zito, MC;
De Caro, C;
Nicoletti, F;
Russo, E;
... Citraro, R; + view all
(2022)
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy.
Molecular Neurobiology
, 59
pp. 2702-2714.
10.1007/s12035-021-02720-3.
|
